May 3rd 2024
A pair of studies from AUA 2024 show neither drinking nor vaping by either parent is associated with significantly increased risk of a spontaneous abortion.
23rd Annual International Congress on the Future of Breast Cancer® East
July 19-20, 2024
Register Now!
15th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 11, 2024
View More
Community Practice Connections™: 14th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies
View More
4th Annual International Congress on the Future of Women’s Health™
View More
Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments
View More
Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions
View More
Osphena Approved by FDA to Treat Dyspareunia
February 27th 2013Osphena (ospemifene) has been approved by the FDA to treat dyspareunia. This is the first non-steroidal estrogen available for women with dyspareunia (painful intercourse), a symptom of vulvar and vaginal atrophy (VVA) that is common during menopause.
Read More
Managing Postmenopausal Symptoms With Nonpharmacological Therapies
February 1st 2013Certain herbal and complementary medicines may be a valuable treatment option for women with postmenopausal symptoms, according to a new review outlining the advantages and limitations of the available treatments of postmenopausal symptoms.
Read More
More Countries Report Cephalosporin-Resistant Gonorrhea
June 18th 2012The number of cases of cephalosporin-resistant gonorrhea is increasing, according to a recent report issued by the World Health Organization. Neisseria gonorrhoeae, the bacteria that causes the infection, has already developed resistance to other common antibiotics, and cephalosporins have become the last line of defense against the infection.
Read More
ACOG: Region Should Factor Into Chlamydia Screening Guidelines For Women Over Age 25
May 14th 2012Women over the age of 25 may still need to be screened for Chlamydia trachomatis (CT) according to research released at the American Congress of Obstetricians and Gynecologists’ (ACOG) Annual Clinical Meeting.
Read More
How to Screen for Intimate Partner Violence: Tools from ACOG
February 29th 2012More than one third of women in the United States will experience some form of intimate partner violence (IPV) in their lifetime. The consequences of IPV can be lifelong and include emotional trauma, long-term physical impairment, chronic health problems, and even death.
Read More
Genital Wart Management: A Partnership Between Physician and Patient
With its implications of sexual transmission and potential cervical cancer, a diagnosis of genital warts can be emotionally distressing to patients. Because no single treatment serves every patient, the best approach to selecting a therapeutic option considers the extent of the disease, wart location, and the patient's individual needs.
Read More
ACOG Committee Urges Treatment for All Cases of VIN
November 1st 2011The American College of Obstetricians and Gynecologists released a new committee opinion urging clinicians to treat all patients presenting with vulvar intraepithelial neoplasia (VIN). The opinion is a result of an increasing incidence of VIN, particularly among US women in their 40s. The full opinion was published in the November issue of Obstetrics & Gynecology.
Read More